MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Parkinson’s Disease (PD) and Type II Diabetes (T2DM): Risk and Progression

    S. Goldman, F. Weaver, L. Cao, B. Gonzalez, S. Jugnundan, K. Stroupe, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

    Objective: To test whether PD risk is greater in those with a prior diagnosis of T2DM, and whether T2DM is associated with faster PD clinical…
  • 2025 International Congress

    Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

    A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)

    Objective: To integrate [18F]-FDG PET (fPET) and objective motor performance to unravel metabolic networks associated with deep brain stimulation (DBS) outcomes in Parkinson’s disease (PD).…
  • 2025 International Congress

    Automatic Intelligibility Rating in Parkinson’s Disease: A Multilingual Approach

    T. Thies, F. Dörr, A. König, N. Linz, M. Barbe, J. Orozco-Arroyave, J. Rusz, J. Tröger (Saarbrücken, Germany)

    Objective: To investigate the validity and robustness of an automatically generated intelligibility score in Parkinson’s disease (PD) across multiple languages. Background: 90% of people with…
  • 2025 International Congress

    Traditional Deep Brain Stimulation Programming versus Automated Image-Guided Algorithm in Patients with Parkinson’s Disease

    H. Maghzi, C. Kim, S. Worthge, C. Malatt, M. Tagliati (Los Angeles, USA)

    Objective: To compare traditional initial deep brain stimulation (DBS) programming with artificial intelligence (AI)-assisted automated image-guided DBS programming algorithm. Background: DBS programming is a complex,…
  • 2025 International Congress

    Electrochemical Sensing for Accurate L-Dopa Detection in Parkinson’s disease

    P. Dutta, A. Eshore, P. Guha, M. Acharya (Kharagpur, India)

    Objective: This study aims to develop a cost-effective, portable electrochemical sensor for real-time L-dopa monitoring in PD patients, addressing the limitations of current detection techniques.…
  • 2025 International Congress

    Expanding the Scope Beyond Neurosurgery: A Systematic Review on MRgFUS Complications

    K. Heintzelman, D. Fletcher, J. Melott, K. Gelman, B. Mendelson, A. Memon (Morgantown, USA)

    Objective: This systematic review aims to investigate the complications associated with MRgFUS (magnetic resonance-guided high intensity focused ultrasound) for neurological disorders and determine their frequency…
  • 2025 International Congress

    Clinical Features Suggestive of Alpha-Synucleinopathy in Progressive Supranuclear Palsy

    C. Painous, A. Martínez-Reyes, J. Santamaria, M. Fernández, A. Cámara, Y. Compta (Barcelona, Spain)

    Objective: To compare the presence of symptoms suggestive of synucleinopathy between PSP-parkinsonism (PSP-P), Parkinson's disease (PD) and PSP-Richardson syndrome (PSP-RS). Background: Clinical signs with high…
  • 2025 International Congress

    A Multidomain Fall Prevention Program: Perspectives of People with Parkinson’s Disease and their Care Partners

    L. Goh, A. Darmali, C. Koch, S. Tran, S. Paul, C. Canning, S. Edwards, S. Harkness, R. Savage, L. Webster, G. Zelma, N. Allen (Camperdown, Australia)

    Objective: To explore the acceptability of a multidomain fall prevention program (Integrate) for people with Parkinson’s disease (PwP) and their care-partners, and factors that influenced…
  • 2025 International Congress

    Tumeric and Curcumin Improve Motor Function and Reduce Catalepsy in a Rotenone -Induced Parkinson’s Disease Model

    L. Darbinyan, L. Hambardzumyan, K. Simonyan, V. Sarkisian, L. Manukyan (Yerevan, Armenia)

    Objective: Catalepsy measurements play a crucial role in behavioral research on Parkinson’s disease (PD), as they reflect significant motor impairments associated with dopaminergic dysfunction. In…
  • 2025 International Congress

    Enhancing Sleep in Parkinson’s Disease: A Retrospective Study on Group CBT-I

    N. Hellmers, A. Weiss, D. Zhang, P. Glovinsky, D. Barone, A. Yoo, H. Ooi, H. Sarva (New York, USA)

    Objective: Weill Cornell Sleep Center and our movement disorder team developed a treatment program for individuals with Parkinson’s Disease (PD) with sleep disturbances. The goal…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley